Wenshan Lv

2.1k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Wenshan Lv is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Wenshan Lv has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 11 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Wenshan Lv's work include Gout, Hyperuricemia, Uric Acid (8 papers), Lipid metabolism and disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Wenshan Lv is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (8 papers), Lipid metabolism and disorders (3 papers) and Alcohol Consumption and Health Effects (3 papers). Wenshan Lv collaborates with scholars based in China, United States and India. Wenshan Lv's co-authors include Yangang Wang, Jingwei Chi, Yue Zhou, George W. Booz, Fan Fan, Richard J. Roman, Yangang Wang, Bingzi Dong, Liyan Shen and Qing Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Wenshan Lv

30 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)

2020 329 citations Yue Zhou, Jingwei Chi et al. Diabetes/Metabolism Research and Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenshan Lv China	14	410	376	288	208	192	32	1.5k
Douwe J. Mulder Netherlands	26	276 0.7×	604 1.6×	102 0.4×	372 1.8×	219 1.1×	97	2.5k
Henriëtte de Loor Belgium	26	591 1.4×	219 0.6×	749 2.6×	68 0.3×	187 1.0×	59	2.2k
Jan Wysocki United States	28	619 1.5×	1.1k 2.9×	310 1.1×	338 1.6×	122 0.6×	66	3.1k
Benjamín Van Tassell United States	31	926 2.3×	554 1.5×	111 0.4×	372 1.8×	391 2.0×	113	3.3k
Hye Eun Yoon South Korea	23	424 1.0×	114 0.3×	585 2.0×	56 0.3×	266 1.4×	110	2.1k
Iain MacPhee United Kingdom	24	197 0.5×	212 0.6×	219 0.8×	44 0.2×	123 0.6×	71	2.4k
Kam Wa Chan Hong Kong	15	198 0.5×	198 0.5×	138 0.5×	90 0.4×	56 0.3×	47	1.1k
Zui Zou China	23	277 0.7×	151 0.4×	59 0.2×	55 0.3×	177 0.9×	66	1.4k
Alessandro Di Minno Italy	31	580 1.4×	209 0.6×	44 0.2×	156 0.8×	379 2.0×	125	3.0k

Countries citing papers authored by Wenshan Lv

Since Specialization

Citations

This map shows the geographic impact of Wenshan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshan Lv more than expected).

Fields of papers citing papers by Wenshan Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshan Lv. The network helps show where Wenshan Lv may publish in the future.

Co-authorship network of co-authors of Wenshan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Wenshan Lv. A scholar is included among the top collaborators of Wenshan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshan Lv. Wenshan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuan, Lili Yang, Libo Yang, et al.. (2025). GLP-1 receptor agonists synergistic effects of metabolic reprogramming and cardioprotection. Frontiers in Endocrinology. 16. 1614726–1614726.

Yang, Libo, Lili Yang, Bingzi Dong, et al.. (2024). The effect of metabolic factors on the association between hyperuricemia and chronic kidney disease: a retrospective cohort mediation analysis. International Urology and Nephrology. 56(7). 2351–2361. 2 indexed citations

Zhang, Fang, Bingzi Dong, Libo Yang, et al.. (2024). Adolescent Takayasu's arteritis with hypertensive intracerebral hemorrhage: a case report and literature review. Frontiers in Pediatrics. 12. 1432362–1432362.

Lv, Wenshan, Lili Xu, Yuhang Zhao, et al.. (2022). Identification of Two Novel Mutations of ABCD1 Gene in Pedigrees with X-Linked Adrenoleukodystrophy and Review of the Literature. International Journal of Endocrinology. 2022. 1–13. 8 indexed citations

Dong, Bingzi, Wenshan Lv, Zhongchao Wang, et al.. (2022). LncRNA ZFAS1 regulates the proliferation, oxidative stress, fibrosis, and inflammation of high glucose-induced human mesangial cells via the miR-588/ROCK1 axis. Diabetology & Metabolic Syndrome. 14(1). 21–21. 9 indexed citations

Wang, Xiang, Jingwei Chi, Bingzi Dong, et al.. (2021). MiR‐223‐3p and miR‐22‐3p inhibit monosodium urate‐induced gouty inflammation by targeting NLRP3. International Journal of Rheumatic Diseases. 24(4). 599–607. 37 indexed citations

Xu, Lili, Yue Zhou, Wenshan Lv, et al.. (2021). Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications. Frontiers in Endocrinology. 12. 770815–770815. 28 indexed citations

Zhou, Yue, et al.. (2020). Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials. Diabetic Medicine. 38(1). e14411–e14411. 14 indexed citations

Zhou, Yue, Jingwei Chi, Wenshan Lv, & Yangang Wang. (2020). Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19). Diabetes/Metabolism Research and Reviews. 37(2). 329 indexed citations breakdown →

10.

Lv, Wenshan, et al.. (2020). Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(10). 2009–2017. 40 indexed citations

11.

Yue, Xiaoyan, Xiaofang Sun, Kui Che, et al.. (2020). Lpl-C310R mutation is associated with impaired glucose tolerance and endoplasmic reticulum stress in skeletal muscle. Biochemical and Biophysical Research Communications. 529(2). 480–486. 2 indexed citations

12.

Zhou, Yue, Qing Yang, Jingwei Chi, et al.. (2020). Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International Journal of Infectious Diseases. 99. 47–56. 269 indexed citations

13.

Zhou, Yue, Liyan Shen, Bingzi Dong, et al.. (2020). Elevated circulating luteinizing hormone levels are associated with diabetic macroalbuminuria in Chinese men and postmenopausal women: A cross‐sectional study. Journal of Diabetes. 12(11). 819–833. 5 indexed citations

14.

Chi, Jingwei, Jing Li, Wei Zhang, et al.. (2017). A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family. PLoS ONE. 12(12). e0189316–e0189316. 9 indexed citations

15.

Lv, Wenshan, George W. Booz, Yangang Wang, Fan Fan, & Richard J. Roman. (2017). Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. European Journal of Pharmacology. 820. 65–76. 245 indexed citations

16.

Xu, Feng, Fang Wang, Zhenhong Wang, et al.. (2016). Glucose Uptake Activities of Bis (2, 3-Dibromo-4, 5-Dihydroxybenzyl) Ether, a Novel Marine Natural Product from Red Alga Odonthaliacorymbifera with Protein Tyrosine Phosphatase 1B Inhibition, In Vitro and In Vivo. PLoS ONE. 11(1). e0147748–e0147748. 25 indexed citations

17.

Chen, Ying, Changgui Li, Shichao Xing, et al.. (2015). CARD8 rs2043211 Polymorphism is Associated with Gout in a Chinese Male Population. Cellular Physiology and Biochemistry. 35(4). 1394–1400. 35 indexed citations

18.

Liu, Ying, Lun Yu, Wenshan Lv, Xu Hou, & Yangang Wang. (2015). A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene. Journal of clinical lipidology. 10(1). 199–203.e1. 10 indexed citations

19.

Lv, Wenshan. (2013). Regulatory effects of ginsenosides on lipid metabolism. 33(2). 115–117. 1 indexed citations

20.

Lv, Wenshan, Changgui Li, Yangang Wang, et al.. (2013). Hypothermia induced by adenosine 5′-monophosphate attenuates early stage injury in an acute gouty arthritis rat model. Rheumatology International. 33(8). 2085–2092. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact